Condition
PCI clinical trials and research
As of November 12, 2026, Find a Trial lists 6 PCI clinical trials that are recruiting, at sites in 4 countries (most in China (3), Uzbekistan (1), Netherlands (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest PCI clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| SiroMax sirolimus-coated balloon for small coronary vessels with or without prior stents | — | Tashkent and 1 other locations | Recruiting | Sep 9, 2026 |
| Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery Disease | — | Chuzhou, Anhui and 6 other locations | Recruiting | Aug 13, 2026 |
| Intravascular imaging–guided versus angiography-guided repeat PCI for drug-eluting stent in-stent restenosis | — | Nanjing, Jiangsu | Recruiting | Dec 22, 2025 |
| Empagliflozin to reduce inflammation after coronary stenting | Phase 4 | Beirut, Beirut | Recruiting | Dec 18, 2025 |
| Bypass surgery versus stents for people with weak heart pumping and blockages in multiple coronary arteries | — | Groningen | Recruiting | Dec 8, 2025 |
| Comparing super high-pressure balloon and intravascular lithotripsy to prepare severely calcified coronary arteries | — | Lianyungang, Jiangsu and 2 other locations | Recruiting | Jul 30, 2025 |
All recruiting trials (6)
-
SiroMax sirolimus-coated balloon for small coronary vessels with or without prior stents
A first-in-human test to see if the SiroMax drug-coated balloon can safely open narrow coronary arteries in adults with or without prior stents.
-
Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery Disease
This registry tests whether delivery time and inflation duration of drug-coated balloons affect outcomes in adults undergoing PCI for new coronary lesions.
-
Intravascular imaging–guided versus angiography-guided repeat PCI for drug-eluting stent in-stent restenosis
This trial tests whether using intravascular imaging (primarily IVUS) to guide repeat PCI gives better clinical and angiographic results than angiography alone for people with drug-eluting stent in-stent restenosis.
-
Empagliflozin to reduce inflammation after coronary stenting
This trial will test whether taking empagliflozin for three days before elective PCI reduces the rise in C‑reactive protein and other inflammatory markers in people with stable coronary artery disease.
-
Bypass surgery versus stents for people with weak heart pumping and blockages in multiple coronary arteries
This trial tests whether bypass surgery (CABG) or stents (PCI) lead to better survival, fewer major heart problems, and improved quality of life for adults with reduced left ventricular function (LVEF ≤40%) and multivessel coronary disease.
-
Comparing super high-pressure balloon and intravascular lithotripsy to prepare severely calcified coronary arteries
This trial tests whether a super high-pressure balloon works as well as intravascular lithotripsy to prepare severely calcified coronary lesions in adults getting drug-eluting stents.
Related topics
Quick answers
How many PCI clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (3 trials), Uzbekistan (1 trial), Netherlands (1 trial), Lebanon (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.